Charles B. O'Keeffe

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Coral Gables, FL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Charles B. O'Keeffe
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Charles B. O'Keeffe

Form 4 holding Director

CATALYST PHARMACEUTICALS, INC.

Security class
Common Stock, par value $0.001 per share
Shares / value
732,470
Estimated value
$1,640,733
Report date
14 Feb 2025
Price
$2.24
Ownership
Direct
Form 4 holding Director

CATALYST PHARMACEUTICALS, INC.

Security class
Restricted Stock Units
Shares / value
208,274
Estimated value
$466,534
Report date
14 Feb 2025
Price
$2.24
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CATALYST PHARMACEUTICALS, INC.

Security class
Options to purchase common stock
Shares / value
213,607
Estimated value
Report date
10 Dec 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Charles B. O'Keeffe

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .